The KFF Health News tracker, updated May 5 2026, charts an accelerating wave of litigation in both state and federal courts after the Supreme Court’s Dobbs decision overturned Roe v. Wade and sent abortion regulation back to the states. Abortion providers and advocacy groups are now challenging state bans under state constitutions and related laws. The tracker also captures new disputes over overlapping federal and state authority on abortion, contraception, and related care. Cases fall into categories such as Pregnancy and Work, Emergency Care, Family Planning, Privacy, Medication Abortion, Minors Access, and State Abortion Bans.
This growing docket shows that the next era of U.S. reproductive policy is being built through state-by-state legal conflict rather than congressional action. For health systems, PBMs, and insurers, diverging case law is fragmenting coverage standards and access rules. It’s pushing organizations to decide how to interpret Medicaid, Title X, and EMTALA obligations in ways that may differ from one jurisdiction to another. If circuit courts split, say, on the legality of cross-state prescriptions for medication abortion, national payers and telehealth networks will have to rewrite coverage and distribution playbooks in real time. Messy, but unavoidable.
In practical terms, reproductive care has turned into a regulatory patchwork, reminiscent of pre-ACA insurance markets where compliance costs and litigation risk kept multiplying. The Supreme Court will likely step back in if circuit-level rulings diverge on contraception or emergency-care mandates. Meanwhile, benefits leaders and employer plans face the tedious but urgent task of continuous contracting reviews and formulary alignment as new restrictions appear. For ongoing analysis of payer exposure and pharmacy policy trends, see PharmaBenefits.ai. The work won’t slow anytime soon, policy is now being written in court filings more than in law books.
